Adagene (ADAG) Total Liabilities (2019 - 2026)
Adagene (ADAG) posted quarterly Total Liabilities of $26.4 million for Q4 2025, down 31.96% year-over-year from $38.7 million in Q4 2024, and down 7.84% quarter-over-quarter from $28.6 million in Q2 2025.
Adagene (ADAG) Total Liabilities (2019 - 2026) Analysis & Trends
Adagene (ADAG) has reported Total Liabilities for 7 consecutive years, with $26.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities fell 31.96% year-over-year to $26.4 million; the TTM figure through Dec 2025 stood at $26.4 million (down 31.96% YoY), while the FY2025 annual figure was $26.4 million, down 31.96% from the prior year.
- Total Liabilities declined to $26.4 million in Q4 2025 per ADAG's latest filing, from $28.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $69.3 million in Q4 2022 and bottomed at $52.51 in Q2 2023.
- Historically, Total Liabilities has averaged $31.7 million across 5 years, with a median of $32.3 million in 2021.
- Annual changes were most pronounced in 2022 — Total Liabilities plunged 100.0% — and 2024, when it surged 84161154.61%.
- Adagene's Total Liabilities stood at $33.0 million in 2021, then surged by 110.33% to $69.3 million in 2022, then tumbled by 34.83% to $45.2 million in 2023, then fell by 14.22% to $38.7 million in 2024, then plunged by 31.96% to $26.4 million in 2025.
- Business Quant data shows ADAG's Total Liabilities at $26.4 million in Q4 2025, $28.6 million in Q2 2025, and $38.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Adagene | 310.54 Mn | 310.54 Mn | - | 27.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.57 Mn |
| Dec 31, 2025 | 26.36 Mn |
| Jun 30, 2025 | 28.60 Mn |
| Dec 31, 2024 | 38.74 Mn |
| Jun 30, 2024 | 44.19 Mn |
| Dec 31, 2023 | 45.17 Mn |
| Jun 30, 2023 | 52.51 |
| Dec 31, 2022 | 69.31 Mn |
| Jun 30, 2022 | 65.87 |
| Dec 31, 2021 | 32.95 Mn |
| Jun 30, 2021 | 31.64 Mn |
| Dec 31, 2020 | 19.20 Mn |
| Dec 31, 2019 | 8.70 Mn |